Makena’s Accelerated Approval Will Hang In Balance At US FDA Panel Meeting In October

 
• By Sue Sutter
  
Pregnant_Woman
Whether Makena should continue to be marketed for preventing preterm birth is the focus of an October AdComm. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers